Cara Therapeutics Files 8-K
Ticker: TVRD · Form: 8-K · Filed: Apr 1, 2025 · CIK: 1346830
| Field | Detail |
|---|---|
| Company | Cara Therapeutics, Inc. (TVRD) |
| Form Type | 8-K |
| Filed Date | Apr 1, 2025 |
| Risk Level | low |
| Sentiment | neutral |
Sentiment: neutral
Topics: corporate-governance, filing, financials
Related Tickers: CARA
TL;DR
Cara Therapeutics filed an 8-K on April 1st, covering votes, other events, and financials. Details TBD.
AI Summary
Cara Therapeutics, Inc. filed an 8-K on April 1, 2025, reporting on matters submitted to a vote of security holders, other events, and financial statements/exhibits. The filing does not contain specific details on the nature of the vote, the other events, or the financial information within the provided text.
Why It Matters
This 8-K filing indicates that Cara Therapeutics has submitted matters for a vote and is providing updates on other events and financial information, which could impact investors' understanding of the company's governance and operations.
Risk Assessment
Risk Level: low — The filing is a standard 8-K for reporting corporate events and does not disclose any immediate financial distress or significant negative news.
Key Players & Entities
- Cara Therapeutics, Inc. (company) — Registrant
- April 1, 2025 (date) — Date of earliest event reported
FAQ
What specific matters were submitted to a vote of security holders by Cara Therapeutics?
The provided text of the 8-K filing does not specify the exact matters submitted to a vote of security holders.
What 'Other Events' are being reported by Cara Therapeutics in this 8-K?
The filing indicates 'Other Events' are being reported, but the specific nature of these events is not detailed in the provided text.
What is the significance of the 'Financial Statements and Exhibits' section in this filing?
This section indicates that financial statements and exhibits are being included with the filing, but their content is not described in the provided text.
When was Cara Therapeutics incorporated, and in which state?
Cara Therapeutics, Inc. was incorporated in Delaware.
What is Cara Therapeutics' principal executive office address?
Cara Therapeutics' principal executive offices are located at 400 Atlantic Street, Suite 500, Stamford, Connecticut 06901.
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on April 1, 2025 regarding Cara Therapeutics, Inc. (TVRD).